KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CRISPR Therapeutics AG (CRSP) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for CRISPR Therapeutics AG (CRSP) over the last 11 years, with Q3 2025 value amounting to -$27000.0.

  • CRISPR Therapeutics AG's Exchange Rate Effect fell 13600.0% to -$27000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $7000.0, marking a year-over-year decrease of 9448.82%. This contributed to the annual value of -$21000.0 for FY2024, which is 12876.71% down from last year.
  • Per CRISPR Therapeutics AG's latest filing, its Exchange Rate Effect stood at -$27000.0 for Q3 2025, which was down 13600.0% from $80000.0 recorded in Q2 2025.
  • In the past 5 years, CRISPR Therapeutics AG's Exchange Rate Effect registered a high of $115000.0 during Q4 2022, and its lowest value of -$100000.0 during Q3 2022.
  • In the last 5 years, CRISPR Therapeutics AG's Exchange Rate Effect had a median value of $3000.0 in 2021 and averaged $2894.7.
  • In the last 5 years, CRISPR Therapeutics AG's Exchange Rate Effect tumbled by 146000.0% in 2022 and then skyrocketed by 390000.0% in 2025.
  • CRISPR Therapeutics AG's Exchange Rate Effect (Quarter) stood at $3000.0 in 2021, then skyrocketed by 3733.33% to $115000.0 in 2022, then tumbled by 46.96% to $61000.0 in 2023, then plummeted by 242.62% to -$87000.0 in 2024, then soared by 68.97% to -$27000.0 in 2025.
  • Its Exchange Rate Effect stands at -$27000.0 for Q3 2025, versus $80000.0 for Q2 2025 and $41000.0 for Q1 2025.